An exceptional case of early onset and prolonged postpartum course of intrahepatic cholestasis of pregnancy is described. Contrary to other drugs tested, ursodeoxycholic acid administered after the 29th week of gestation improved pruritus and decreased bile acid leveis both in serum and amniotic fluid. Labour was induced at 36 weeks, and a female weighing 2.050 g and with an Apgar score of nine was born. Ursodeoxycholic acid, by decreasing the passage of bile acids to the foetus, may have improved the outcome of the pmegnancy. © 1998 Elsevier Science Ireland Ltd.info:eu-repo/semantics/publishedVersio
Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeox...
BACKGROUND: Intrahepatic cholestasis of pregnancy, characterised by maternal pruritus and increased ...
Intrahepatic cholestasis of pregnancy (ICP) is the most frequent pregnancy-specific liver disease. I...
An exceptional case of early onset and prolonged postpartum course of intrahepatic cholestasis of pr...
In an open, pilot study, the efficacy and safety of ursodeoxycholic acid (UDCA) in the treatment of ...
Background/Aims: Intense pruritus and the risk of stillbirths and premature deliveries justify the s...
Background Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, yet...
Obstetric Cholestasis is the commonest liver disease that causes pruritis and is unique to pregnancy...
Background/Aims: Intrahepatic cholestasis of pregnancy is characterized by pruritus and increased le...
BACKGROUND & AIMS: Treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid appe...
Aim of the lecture. To present the modern concept of etiology and pathogenesis of the intrahepatic c...
OBJECTIVE: To test the efficacy and safety of ursodeoxycholic acid (UDCA) in the treatment of intra...
BACKGROUND: Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, ye...
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease specific to pregnancy. ...
Objectives: To test whether ursodeoxycholic acid reduces pruritus in women with intrahepatic cholest...
Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeox...
BACKGROUND: Intrahepatic cholestasis of pregnancy, characterised by maternal pruritus and increased ...
Intrahepatic cholestasis of pregnancy (ICP) is the most frequent pregnancy-specific liver disease. I...
An exceptional case of early onset and prolonged postpartum course of intrahepatic cholestasis of pr...
In an open, pilot study, the efficacy and safety of ursodeoxycholic acid (UDCA) in the treatment of ...
Background/Aims: Intense pruritus and the risk of stillbirths and premature deliveries justify the s...
Background Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, yet...
Obstetric Cholestasis is the commonest liver disease that causes pruritis and is unique to pregnancy...
Background/Aims: Intrahepatic cholestasis of pregnancy is characterized by pruritus and increased le...
BACKGROUND & AIMS: Treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid appe...
Aim of the lecture. To present the modern concept of etiology and pathogenesis of the intrahepatic c...
OBJECTIVE: To test the efficacy and safety of ursodeoxycholic acid (UDCA) in the treatment of intra...
BACKGROUND: Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, ye...
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease specific to pregnancy. ...
Objectives: To test whether ursodeoxycholic acid reduces pruritus in women with intrahepatic cholest...
Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeox...
BACKGROUND: Intrahepatic cholestasis of pregnancy, characterised by maternal pruritus and increased ...
Intrahepatic cholestasis of pregnancy (ICP) is the most frequent pregnancy-specific liver disease. I...